Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

Tadeusz Robak, Jan A. Burger, Alessandra Tedeschi, Paul M. Barr, Carolyn Owen, Osnat Bairey, Peter Hillmen, David Simpson, Sebastian Grosicki, Stephen Devereux, Helen McCarthy, Steven E. Coutre, Hang Quach, Gianluca Gaidano, Zvenyslava Maslyak, Don A. Stevens, Carol Moreno, Devinder S. Gill, Ian W. Flinn, John G. GribbenAhmad Mokatrin, Mei Cheng, Lori Styles, Danelle F. James, Thomas J. Kipps, Paolo Ghia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies'. Together they form a unique fingerprint.

Medicine & Life Sciences